Study Brief | The purpose of this research study is to determine genes that affect how a person’s body metabolizes a drug can help us predict how women will respond to a FDA approved medication (fesoterodine fumarate) for urgency urinary incontinence (UUI).
Study Brief | The purpose of the ACE trial is to assess cognitive function in women taking an anticholinergic medication (trospium) for the treatment of overactive bladder. This medication is FDA-approved and is not experimental. There are rare reports of changes in cognitive function when taking any anticholinergic medication for overactive bladder. The goal is to administer written cognitive function tests to measure your cognitive function before and after starting medication.